TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,204,856
|
779,672
|
680,916 |
Financial expenses |
269
|
57
|
87 |
Earnings before taxes |
48,019
|
34,200
|
20,918 |
EBITDA |
44,687
|
33,407
|
21,075 |
Total assets |
327,496
|
298,968
|
285,214 |
Current assets |
327,322
|
298,722
|
284,868 |
Current liabilities |
214,806
|
203,591
|
209,100 |
Equity capital |
85,532
|
66,549
|
50,946 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
110
|
115
|
106 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.1%
|
22.3%
|
17.9% |
Turnover per employee |
10,953
|
6,780
|
6,424 |
Profit as a percentage of turnover |
4.0%
|
4.4%
|
3.1% |
Return on assets (ROA) |
14.7%
|
11.5%
|
7.4% |
Current ratio |
152.4%
|
146.7%
|
136.2% |
Return on equity (ROE) |
56.1%
|
51.4%
|
41.1% |
Change turnover |
421,168
|
153,911
|
-23,339 |
Change turnover % |
54%
|
25%
|
-3% |
Chg. No. of employees |
-5
|
9
|
11 |
Chg. No. of employees % |
-4%
|
8%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.